Interleukin 28B genotype determination using DNA from different sources: A simple and reliable tool for the epidemiological and clinical characterization of hepatitis C

2011 ◽  
Vol 178 (1-2) ◽  
pp. 235-238 ◽  
Author(s):  
Elisabetta Cariani ◽  
Rosina Critelli ◽  
Cristina Rota ◽  
Monica Luongo ◽  
Tommaso Trenti ◽  
...  
Keyword(s):  
Hepatitis C ◽  
Interleukin 28B ◽  
Reliable Tool ◽  
Different Sources

scholarly journals Characterization of the Interleukin-28B Gene rs12979860 C/T Polymorphism in Turkish Chronic Hepatitis C Patients and Healthy Individuals

2015 ◽  
Vol 32 (2) ◽  
pp. 147-155 ◽  
Author(s):  
Serpil Taheri ◽  
Bilgehan Aygencel ◽  
Keziban Korkmaz ◽  
Orhan Yildiz ◽  
Gokmen Zararsiz ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Healthy Individuals ◽  
Interleukin 28B ◽  
Chronic Hepatitis C Patients

Association of Interleukin 28B Polymorphism with Clearance of Hepatitis C Virus: A Mini Review

2020 ◽  
Vol 30 (3) ◽  
pp. 223-229
Author(s):  
Mahrukh Shaheen ◽  
Samia Afzal ◽  
Bushra Khubaib ◽  
Iram Amin ◽  
Muhammad Shahid ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Interleukin 28B

scholarly journals Microfluidic Tools for Enhanced Characterization of Therapeutic Stem Cells and Prediction of Their Potential Antimicrobial Secretome

Antibiotics ◽  
2021 ◽  
Vol 10 (7) ◽  
pp. 750
Author(s):  
Pasquale Marrazzo ◽  
Valeria Pizzuti ◽  
Silvia Zia ◽  
Azzurra Sargenti ◽  
Daniele Gazzola ◽  
...  
Keyword(s):  
Stem Cells ◽  
Defense Mechanisms ◽  
Live Cells ◽  
Label Free ◽  
Bacterial Diseases ◽  
Prospective Application ◽  
Therapy Strategies ◽  
Stromal Stem Cells ◽  
Different Sources

Antibiotic resistance is creating enormous attention on the development of new antibiotic-free therapy strategies for bacterial diseases. Mesenchymal stromal stem cells (MSCs) are the most promising candidates in current clinical trials and included in several cell-therapy protocols. Together with the well-known immunomodulatory and regenerative potential of the MSC secretome, these cells have shown direct and indirect anti-bacterial effects. However, the low reproducibility and standardization of MSCs from different sources are the current limitations prior to the purification of cell-free secreted antimicrobial peptides and exosomes. In order to improve MSC characterization, novel label-free functional tests, evaluating the biophysical properties of the cells, will be advantageous for their cell profiling, population sorting, and quality control. We discuss the potential of emerging microfluidic technologies providing new insights into density, shape, and size of live cells, starting from heterogeneous or 3D cultured samples. The prospective application of these technologies to studying MSC populations may contribute to developing new biopharmaceutical strategies with a view to naturally overcoming bacterial defense mechanisms.

scholarly journals Characterization of a hepatitis C virus genotype 1 divergent isolate from an HIV-1 coinfected individual in Germany assigned to a new subtype 1o

2019 ◽  
Vol 16 (1) ◽  
Author(s):  
Bo Wang ◽  
Luise Krüger ◽  
Patrycja Machnowska ◽  
Amare Eshetu ◽  
Barbara Gunsenheimer-Bartmeyer ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Hiv 1

scholarly journals Characterization of Resistance to Non-obligate Chain-terminating Ribonucleoside Analogs That Inhibit Hepatitis C Virus Replicationin Vitro

2003 ◽  
Vol 278 (49) ◽  
pp. 49164-49170 ◽  
Author(s):  
Giovanni Migliaccio ◽  
Joanne E. Tomassini ◽  
Steven S. Carroll ◽  
Licia Tomei ◽  
Sergio Altamura ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C
Sign in / Sign up

Export Citation Format

Share Document